Revvity Inc(RVTY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 4:09 PM ET (Korea 10/27 05:09)
Full metrics table
| Index | S&P 500 | P/E | 76.17 | EPS (ttm) | 2.11 | Insider Own | 0.47% | Shs Outstand | 111.6M | Perf Week | 6.26% |
| Market Cap | 17.90B | Forward P/E | 27.22 | EPS next Y | 10% | Insider Trans | -1.71% | Shs Float | 111.1M | Perf Month | 6.14% |
| Enterprise Value | 20.22B | PEG | 3.2 | EPS next Q | 1.3 | Inst Own | 104.3% | Short Float | 5.67% | Perf Quarter | 43.83% |
| Income | 0.24B | P/S | 6.15 | EPS this Y | 5.86% | Inst Trans | 6.2% | Short Ratio | 3.44 | Perf Half Y | 84.78% |
| Sales | 2.91B | P/B | 2.48 | EPS next 5Y | 8.51% | ROA | 1.94% | Short Interest | 6.30M | Perf YTD | 65.78% |
| Book/sh | 64.78 | P/C | 17.48 | EPS past 3/5Y | -22.75% -20.4% | ROE | 3.21% | 52W High | -3.52% ($166.25) | Perf Year | 62.19% |
| Cash/sh | 9.17 | P/FCF | 32.07 | Sales past 3/5Y | -4.82% -5.47% | ROIC | 2.38% | 52W Low | 97.48% ($81.22) | Perf 3Y | 62.09% |
| Dividend Est. | $0.28 (0.18%) | EV/EBITDA | 23.45 | EPS Y/Y TTM | -10.4% | Gross Margin | 48.19% | Volatility(W/M) | 3.62% 3.83% | Perf 5Y | -9.37% |
| Dividend TTM | 0.28 | EV/Sales | 6.94 | Sales Y/Y TTM | 4.05% | Oper. Margin | 15.45% | ATR (14) | 5.66 | Perf 10Y | 216.91% |
| Dividend Ex-Date | 2026/10/23 | Quick Ratio | 1.5 | EPS Q/Q | -0.88% | Profit Margin | 8.18% | RSI (14) | 67.59 | Recom | 2.57 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.8 | Sales Q/Q | 1.31% | SMA20 | 3.91% ($154.35) | Beta | 1.08 | Target Price | $149.36 |
| Payout | 13.49% | Debt/Eq | 0.46 | Earnings | 2026/11/3 | SMA50 | 13.79% ($140.95) | Rel Volume | 0.59 | Prev Close | $158.77 |
| Employees | 11000 | LT Debt/Eq | 0.38 | EPS/Sales Surpr. | 16.16% 1.14% | SMA200 | 44.78% ($110.78) | Avg Volume(3M) | 1.83M | Price | $160.39 |
| IPO | 1965/7/6 | Option/Short | Yes/Yes | Trades | 14853 | Volume | 1,089,353 | Change | 1.02% |
A life sciences and diagnostics company based in the US that supplies research reagents and instruments, diagnostic solutions such as newborn screening tests, and software to pharmaceutical, biotech, and hospital clients. The company rebranded from its former name, PerkinElmer.
Over the past 1 year, on the higher side
4% below its 1-year high.
Traded less than usual. That is 59% of its average volume.
Next earnings report: November 3
7 days to go.
RVTY has a sound balance sheet but weak earning power
After all costs, only $8.18 of every $100 in sales is left.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +5.9% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $2,722. Peers typically go for $2,743. Compared with its own 5-year average, it is 111% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -9.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.18% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 104.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #14 of 44 in the industry
Based on market cap of $18B.
FAQ
What kind of company is RVTY?
RVTY belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of RVTY?
The market cap of RVTY is approximately $17.9B, ranking 638 within its sector.
Does RVTY pay dividends?
RVTY has a dividend yield of approximately 0.18%, with an annual dividend of $0.28.
What is the P/E ratio of RVTY?
RVTY has a P/E ratio of approximately 76.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for RVTY?
RVTY has recorded a 52-week high of $166.25 and a low of $81.22.
